Jan L.
- Country
- Poland
- Department
- Centrum Zdrowia Psychicznego BIOMED Jan Latala
Research Overview
- Oral semaglutide versus placebo in early Alzheimer’s disease: a randomized double-blind trial in patients with mild cognitive impairment or mild dementia
- Evaluation of RL-007 on Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
- Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of AVP‑786 (deudextromethorphan hydrobromide/quinidine) for Agitation in Alzheimer’s Dementia
Data & Insights
Has run more than one trial at 109 of 205 partner sites.
Specializations
Cognitive and Psychiatric Disorders
The investigator specializes in treating cognitive impairment associated with schizophrenia, focusing on innovative therapeutic approaches for patients with dual diagnoses. Their research encompasses comprehensive evaluation of cognitive performance in individuals with schizophrenia spectrum disorders.
- Cognitive Disorders
- Schizophrenia Treatment
- Cognitive Performance Assessment
Mood Disorders
The investigator conducts research in the treatment of Major Depressive Disorder, with particular attention to therapeutic interventions for outpatients. Their work includes evaluation of novel treatment approaches for depression, focusing on patients with specific genetic profiles.
- Depression Management
- Outpatient Treatment Protocols
- Personalized Medicine Approaches
Neurodegenerative Conditions
The investigator focuses on treating complex manifestations of Alzheimer's Disease, including psychosis and agitation. Their expertise extends to managing behavioral symptoms in dementia patients, utilizing both innovative and established therapeutic approaches.
- Alzheimer's-Related Psychosis
- Agitation Management
- Behavioral Symptom Control
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.